J. Lyle Bootman, PhD, ScD
Senior Vice President for Health Sciences
Dean, College of Pharmacy
Professor: Pharmacy, Medicine, Public Health
Founding Executive Director, Center for Health Outcomes & PharmacoEconomic Research
Dr. Bootman is senior vice president for health sciences at the University of Arizona and has served as dean of the UA College of Pharmacy since 1987. He is professor of pharmacy, medicine and public health, and a fellow of several professional associations, including the American Pharmacists Association, American Association of Pharmaceutical Scientists and the American College of Apothecaries. He is the founding and executive director of the University of Arizona Center for Health Outcomes and PharmacoEconomic (HOPE) Research, one of the first such centers developed in the world. He is also a founding director of the Healthcare Transformation Institute (HTI), the first company launched to truly advance our country’s healthcare system by developing new delivery models in improving patient health care value, patient outcomes, and services. He is former president of the American Pharmacists Association and president emeritus of the Pharmacy & Therapeutics Society.
He received his pharmacy education at the University of Arizona and his doctorate at the University of Minnesota, where he was given the “Outstanding Achievement Award,” the university’s highest alumni honor. He completed a clinical pharmacy residency at the world-renowned National Institutes of Health, and received an honorary doctorate from the University of the Sciences in Philadelphia, the first such institution founded in the United States in 1821. Most recently he was honored with an honorary doctorate from The Ohio State University.
Dr. Bootman has authored more than 285 research articles, books and monographs, and has been an invited speaker at more than 600 professional healthcare meetings and symposia. He was selected as one of the 50 most influential pharmacists in the U.S. by American Druggist, and has received numerous outstanding scientific achievement awards, most notably from the American Association of Pharmaceutical Scientists and the Academy of Pharmaceutical Science and Research for his research which pioneered the field of pharmacoeconomics and health outcomes. He has published several books including the first textbook introducing the principles of pharmacoeconomics, which is utilized in more than 40 countries and translated in seven languages. His research regarding the outcomes of drug-related morbidity and mortality receives worldwide attention by the professional and the public media.
Additionally, he is an elected member of the Institute of Medicine of the National Academies, where he served on the Board of Health Care Services for seven years, and was co-chair of the IOM committee which released the highly publicized report “Preventing Medication Errors.” He serves as an adviser to leading pharmaceutical companies, universities and healthcare organizations throughout the world. Currently, he serves on several prestigious boards, including HTI, The Critical Path Institute, Research Corporation Technologies, CMR Institute, First Databank and Madeira Therapeutics.
Dr. Bootman has received numerous honors and awards. He was the recipient of the George Archambault Award, the highest honor given by the American Society of Consultant Pharmacists; the Latiolais Honor Medal, the highest honor in managed health care by the Pharmaceutical Care Management Association; and the Hugo H. Schaefer Award, which recognizes outstanding lifetime contributions to the organization, the profession and to society, given by the American Pharmacists Association. In 2008, he was recognized with the Joseph P. Remington Honor Medal, the highest honor given by the profession of pharmacy to recognize distinguished service and lifetime contributions.
Education
University of Arizona, College of Pharmacy, BS, 1974, Pharmacy
University of Minnesota, MS, 1976, Pharmacy Administration
University of Minnesota, PhD, 1978, Pharmacy Administration
Honors, Awards, and Fellowships
1970-1974 Health Professions Scholarship, The University of Arizona College of Pharmacy
1970-1974 Dean's Honor List, University of Arizona College of Pharmacy
1973 Outstanding Junior, Kappa Psi Pharmacy Fraternity, The University of Arizona
1973 Outstanding Junior, Alpha Zeta Omega Award, The University of Arizona
1973 Elected to Rho Chi National Pharmacy Honorary Society and served as President,1973 - 1974
1974 Phi Kappa Phi National Collegiate Honorary Society
Publications
Bootman JL. Pharmacy Today & Tomorrow, Saudi Pharmaceutical Journal 1993; 1 (1): 38-39.
Bootman JL. Principles of Pharmacoepidemiology Saudi Pharmaceutical Journal 1993, 1(1): 43-44.
Chinburapa V, Larson L, Brucks, M, Draugalis J, Bootman, JL & Puto C: Physician Prescribing Decisions: The effects of Situational Involvement & Task Competing on Information Acquisitional Decision Making, Social Science Medicine, 1993; 36 1(1): 1473-1482.
Bootman JL, Introduction Health Care Reform - Pharmaceutical Representative, October 1993.
Bootman JL, The Clinton Health Care Reform Proposal, Pharmaceutical Representative, November 1993.
Bootman JL, The Impact of Health Care Reform, Pharmaceutical Representative, December 1993.
Mackeigan L, Larson L, Draugalis J, Bootman JL, Burns L. Time Preference for Health Gains Versus Health Losses, Pharmacoeconomics 1993: 3 (5) 374-386.
Bootman JL, Managing Conflict in the Academic Setting American Journal of Pharmaceutical Education. 1994: 58 (Spring): 1-21.
Harrison DL, Bootman JL, Strategic Planning by Institutional Pharmacy Administrators, Journal of Pharmaceutical Marketing and Management 1994: 8 (2): 73-96.
Bootman JL, Current Trends in Health Care Delivery, Pharmaceutical Representative November 1994.
Bootman JL, Changing Roles of Health Care Providers, Pharmaceutical Representative, December 1994.
Johnson J. Bootman JL, Pharmacoeconomic analysis in formulary decisions: An international perspective, Commentary, Am J Hosp Pharm. October 1994: 51, 2593-2597.
Bootman JL, Bungay K, Schulman K, The Role of Industry in Disease Management, Part II, Pharmaceutical Representative, March 1995.
Johnson J, Bootman JL, Drug Related Morbidity and Mortality in the United States, Archives of Internal Medicine, Volume 155, October 9, 1995, 1949-1956
Bootman JL. Principles of Pharmacoepidemiology, Saudi Pharmaceutical Journal 1993; 1(1): 43-44
Chinburapa V, Larson L, Brucks, M, Draugalis J, Bootman, JL & Puto C: Physician Prescribing Decisions: The effects of Situational Involvement & Task Competing on Information Acquisitional Decision Making, Social Science Medicine, 1993; 36 1(1): 1473-1482
Bootman JL, Introduction Health Care Reform, J. Pharm. Rep., 1993; 23 (12): 4-6.
Bootman JL, The Clinton Health Care Reform Proposal, J. Pharm. Rep., 1993; 23 (11): 4-6.
Bootman JL, The Impact of Health Care Reform, J. Pharm. Rep., 1993; 23(12): 4- 6.
Mackeigan L, Larson L, Draugalis J, Bootman JL, Burns L. Time Preference for Health Gains Versus Health Losses, Pharmacoeconomics 1993; 3(5): 374-386.
Bootman JL, Managing Conflict in the Academic Setting, American Journal of Pharmaceutical Education. 1994; 58(Spring): 1-21.
Harrison DL, Bootman JL, Strategic Planning by Institutional Pharmacy Administrators, Journal of Pharmaceutical Marketing and Management 1994; 8 (2): 73-96.
Bootman JL, Current Trends in Health Care Delivery, J. Pharm. Rep., 1994; 24 (11): 5-7.
Bootman JL, Changing Roles of Health Care Providers, J. Pharm. Rep., 1994; 24 (12): 4-6.
Johnson J. Bootman JL, Pharmacoeconomic analysis in formulary decisions: An international perspective, Commentary, Am J Hosp Pharm. October 1994; 51: 2593-2597.
Bootman JL, New Directions for the Pharmacist, J. Pharm. Rep., 1995; 25 (1): 4-7.
Bootman JL, Bungay K, Schulman K, Introduction to Disease Management, J. Pharm. Rep., 1995; 25(2): 4-7.
Bootman JL, Bungay K, Schulman K, The Role of Industry in Disease Management, J. Pharm. Rep., 1995; 25 (3): 4-6.
Bootman JL, Noel M, Sampling on the Line, Pharmaceutical Executive, 1995; 15 (3): 86-90.
Bootman JL, Nash D, Advanced Concepts in Managed Healthcare: Evolution of Integrated Healthcare Systems, J. Pharm. Rep., 1995; 25 (6): 4-6.
Bootman JL, Nash D, Advanced Concepts In Managed Healthcare: Models of Integrated Healthcare Delivery, J. Pharm. Rep., 1995; 25 (7): 3-5.
Bootman JL, Nash D, Advanced Concepts in Managed Healthcare: Role of the Pharmaceutical Industry in Integrated Healthcare Systems, J. Pharm. Rep., 1995; 25 (8): 4-7.
Johnson J, Bootman JL, Drug Related Morbidity and Mortality: A Cost of Illness Model, Archives of Internal Medicine, 1995; 155: October 9, 1949-1956
Bootman JL, Pharmacoeconomics and Outcomes Research, AJHP, 1995; 52 (3): July 15, 16-19.
Bootman JL, Chair Report. Academic Affairs Committee. American Journal of Pharmaceutical Education 1995; 59 (4): 1-3.
Bootman JL, Pharmacoeconomics: An Emerging Discipline for the Pharmacy Profession, Pharmacy World and Science, 1996; 18 (1): 3-4.
Bootman JL, Milne R, Costs, Innovation and Efficiency in Antiinfective Therapy, Pharmacoeconomics, 1996; 9 (Suppl-1): 31-39
Bootman JL, The $76 Billion Wake-up Call, J. Amer. Pharm. Assoc. 1996; NS36 (1): 27-28
Bootman JL, Pharmacoeconomics and Therapeutic Drug Monitoring, Marketing for Health 1996; 6 (2): 10-12. Gouveia WA,
Bootman JL, The Outcomes Movement of Its Influence as the Future of Pharmacy Practice and Research, Actes DV XXXII Congress Internationale D'Historie De La Pharmacie Proceedings, Paris, France, 1996; (2): 256-288. Kortt MA,
Bootman JL, The Economics of Benign Prostatic Hyperplasia Treatment: A Literature Review, Clinical Therapeutics, 1996; 18 (6): 1227-1241
Bootman JL, and Martin RE, Current Trends in Managed Healthcare Part I, Pharmaceutical Representatives, 1997; 27 (1): 3-5.
Bootman JL, and Martin RE, Current Trends in Managed Healthcare Part II, Pharmaceutical Representation, 1997; 27 (2): 3-5.
Johnson J, Bootman JL, Drug Related Morbidity and Mortality and the Economic Impact of Pharmaceutical Care, Am. J. Health Systems Pharmacy, 1997: 54 (Mar 1): 554-558
Bootman JL, Martin RE, Current Trends in Managed Healthcare Part III, Pharmaceutical Representative 1997; 27(2): 5-7
Bootman JL, Harrison D, Pharmacoeconomics of Therapeutic Drug Monitoring, Pharmacy World and Science, 1997; 19(3): 1-4
Bootman JL, Harrison D, Cox E, The Healthcare Cost of Drug-Related Morbidity and Mortality in Nursing Facilities, Archives of Internal Medicine, 1997: 157 (Oct 13): 2089-2096
Bootman JL, and Langley P, Pharmacoeconomics, Prescribing and Reimbursement of Pharmaceuticals, J. Applied Therapeutics, 1997; 1(1): 275-283
Bootman, JL Bungay K, Outcomes in the Health Care Marketplace, Pharmaceutical Representative 1998; 28(6): 25-28
Bootman JL, Piech C, Cost Effectiveness of Two New Treatments for onychomycosis: An Analysis of Two Comparative Clinical Trials, J. Amer. Acad. Dermatology, 1998; 38: S69-72